494 filings
Page 2 of 25
8-K
yre1388nqv9ddc kf
5 May 23
Entry into a Material Definitive Agreement
5:16pm
8-K
qsr69hdexq gnpd116sl
3 May 23
Dexcom Prices Upsized Offering of $1.1 Billion of 0.375% Convertible Senior Notes Due 2028
7:19am
8-K
sk49w1
2 May 23
Dexcom Announces Proposed Offering of $1.0 Billion of Convertible Senior Notes
7:16am
8-K
1ikhgdic2s
27 Apr 23
Dexcom Reports First Quarter 2023 Financial Results
12:00am
ARS
sa3k5
6 Apr 23
Annual report to shareholders
4:54pm
DEFA14A
u6q9s
6 Apr 23
Additional proxy soliciting materials
4:16pm
8-K
9b6zwqfh
9 Feb 23
Dexcom Reports Fourth Quarter and Fiscal Year 2022 Financial Results
4:05pm
8-K
1x5yo r5901qn2i7qw
9 Jan 23
Dexcom Reports Preliminary, Unaudited Revenue for the Fourth Quarter and Fiscal Year 2022 and Initial 2023 Outlook
8:03am
8-K
v3h5q33a rt
27 Oct 22
Dexcom Reports Third Quarter 2022 Financial Results
4:05pm
8-K
kabt965m611o8
31 Aug 22
Departure of Directors or Certain Officers
5:01pm
8-K
0753i u5pbibc38
5 Aug 22
Other Events
4:52pm
8-K
4i46y m8izg
28 Jul 22
Other Events
4:23pm
8-K
y24v906
28 Jul 22
Dexcom Reports Second Quarter 2022 Financial Results
4:07pm
8-K
1hdglifrrtv0
8 Jul 22
Departure of Directors or Certain Officers
4:30pm
8-K
io6xmb
10 Jun 22
Amendments to Articles of Incorporation or Bylaws
4:01pm